Treatment with a specified drug

Cardiomyopathy - Treatment with a specified drug Factor

Last reviewed for CCPS 18 July 2007.

Investigative Documents

Medical Report - Use of a Specified Drug - Cardiomyopathy [MR9383]

Preliminary questions [38079]

38080

there is some evidence that being treated with a specified drug for cardiomyopathy may be a factor in the development or worsening of the condition under consideration.

38350 the veteran was being treated with a specified drug for cardiomyopathy for treatment of an illness or injury which is identifiable.

38083 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and VEA service for cardiomyopathy.

38081

for the identified illness or injury, the veteran was being treated with a specified drug for cardiomyopathy within the seven days before the clinical onset of the condition under consideration.

38084 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and VEA service for the clinical onset of cardiomyopathy.

38086 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and operational service for the clinical onset of cardiomyopathy.

or

38087 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and eligible service for the clinical onset of cardiomyopathy.

or

7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

38082

for the identified illness or injury, the veteran was being treated with a specified drug for cardiomyopathy within the seven days before the clinical worsening of the condition under consideration.

38085 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and VEA service for the clinical worsening of cardiomyopathy.

38088 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and operational service for the clinical worsening of cardiomyopathy.

or

38089 — the veteran has established the causal connection between being treated with a specified drug for cardiomyopathy and eligible service for the clinical worsening of cardiomyopathy.

Clinical onset and operational service [38086]

38351 — the identified illness or injury, for which the veteran was being treated with a specified drug for cardiomyopathy, is causally related to operational service.

Clinical onset and eligible service [38087]

38352 — the identified illness or injury, for which the veteran was being treated with a specified drug for cardiomyopathy, is causally related to eligible service.

Clinical worsening and operational service [38088]

38351 — the identified illness or injury, for which the veteran was being treated with a specified drug for cardiomyopathy, is causally related to operational service.

38092

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury, for which the veteran was being treated with a specified drug for cardiomyopathy, is causally related.

Clinical worsening and eligible service [38089]

38352 — the identified illness or injury, for which the veteran was being treated with a specified drug for cardiomyopathy, is causally related to eligible service.

38093

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury, for which the veteran was being treated with a specified drug for cardiomyopathy, is causally related.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/c-d/cardiomyopathy-g021-4254-425964866748/rulebase-cardiomyopathy/treatment-specified-drug